Hu, Xiaohan
Chirovsky, Diana
Walker, Mark S.
Wang, Yuexi
Kaushiva, Alpana
Tepsick, Jon
Samkari, Ayman
Funding for this research was provided by:
Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA
Article History
Received: 2 June 2023
Accepted: 30 June 2024
First Online: 10 July 2024
Declarations
:
: This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This research was reviewed and determined to be exempt from Institutional Review Board (IRB) oversight by Advarra IRB (Columbia, Maryland, U.S.). Informed consent was not applicable for the research described in this article. This research study was conducted retrospectively from data obtained for clinical purposes. The data used in this study were all collected originally for clinical use in the practice setting and are therefore considered secondary data. Only de-identified data were utilized in the analysis, and unique patient identifiers were completely removed from the analytical dataset.
: Not applicable.
: XH, DC, and AS are employed by Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA and hold stock or stock options in Merck & Co., Inc., Rahway, NJ, USA.MSW, YW, AK, and JT report research funding to their institution from Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA.